DANIEL CORREA: Open Payments
NPI 1437745205 · SUNRISE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 83 payments from 21 companies in 2025. Trend: 2023 $46 · 2024 $1,499 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $272 |
| AstraZeneca Pharmaceuticals LP | 10 | $215 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $189 |
| Lilly USA, LLC | 8 | $163 |
| PFIZER INC. | 9 | $155 |
| GlaxoSmithKline, LLC. | 10 | $142 |
| Amgen Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $57 |
| Exact Sciences Corporation | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
Products named: JARDIANCE, NURTEC ODT, Ozempic, AIRSUPRA, Wegovy, TRELEGY ELLIPTA, ZEPBOUND, MOUNJARO.
Industry payments across FL — which companies pay providers there.
